Essential Pro

Paclitaxel eluting coronary balloon dilatation catheter
The novel reliable DCB

PRODUCT FEATURES

Optimal navigation

High pushability
Improved transition lumen

Improved visibility
Pt/Ir MRO

Excellent trackability
Hydrax plus

Coating technology matters Not all DCBs are the same

Has a ultrathin coating thanks to the nano drop technology used to coat the balloons.
Ensures a durable coating due to its multilayer technology.
Ensures a uniform artery treatment

CLINICAL SUPPORT

Essential pro has proven its safety and efficacy in the following clinical trials and registries

Small Vessels Registry

Observational, prospective and multicenter registry 4.2% TLF at 12 months

ISR Study

Observational, prospecive, multicenter and investigator-initiated study 51.4% In segment maximal area stenosis at 6 months

Angiolite

Coronary sirolimus stent
The DES we trust

PRODUCT FEATURES

Excellent performance even in compromised situations

Left Main and bifurcation lesions: One of the highest overexpansion capacity for large vessels 6.00mm

75µm
Small vessels:
Adapted to the need of the arteries with thin struts

Diffuse lesions: new available lengths 44 & 49mm

Calcified lesions: excellent arterial support +40% vs competitors

High quality of healing

TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score.
Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer. This mechanism suggest to reduce stent thrombosis.

CLINICAL SUPPORT

Angiolite has proven its safety and efficacy in the following clinical trials and registries

ANCHOR Study

Observational, prospective, multicenter study 86.3% Strut coverage at 3 months

ANGIOLITE Trial

Randomized, non-inferiority, observational, prospective, multicenter trial 0.04mm LLL at 6 months

RANGO Registry

Prospective, single arm, multicenter observational registry 3.4% TLF at 2 year